½ÃÀ庸°í¼­
»óǰÄÚµå
1279861

¼¼°èÀÇ ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø, Á¦Ç°º°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Label-Free Detection Market Size study & Forecast, by product, by Technology, by Application, by End-user and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹«Ç¥Áö °ËÃâ(LFD : Label-Free Detection)Àº ¶óº§À̳ª ¸¶Ä¿¸¦ »ç¿ëÇÏÁö ¾Ê°í »ýüºÐÀÚ¸¦ ŽÁöÇϰí Á¤·®È­ÇÒ ¼ö ÀÖ´Â ±â¼ú°ú µµ±¸¸¦ ¸»ÇÕ´Ï´Ù.

¿©±â¿¡´Â Ç¥¸é ÇöóÁî¸ó °ø¸í(SPR), »ýüÃþ °£¼·¹ý(BLI), µî¿Â ÀûÁ¤ Ä®·Î¸®¸ÞÆ®¸®(ITC), Ä®·Î¸®¸ÞÆ®¸® ±â¹Ý ºÐ¼® µî ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ½ÃÀå ¼ºÀåÀº ¹«Ç¥Áö °ËÃâ ±â¼ú °í°¨µµÈ­¿Í â¾à ÇÁ·Î±×·¥ Áõ°¡¿Í °°Àº ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù.

LFD ¹æ¹ýÀº ³×ÀÌÆ¼ºê ´Ü¹éÁú°ú ¸®°£µå¸¸À» »ç¿ëÇϹǷΠº¸´Ù Á¤È®ÇÑ Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖ´Â ±âº»ÀûÀÎ ÀÌÁ¡ÀÌ ÀÖ½À´Ï´Ù. Ç¥¸é °­È­ ·¹ÀÌÀú Å»Âø ÀÌ¿ÂÈ­(SELDI) ºñÇà ½Ã°£Çü(TOF) Áú·® ºÐ¼®(MS) °³¹ßÀº Ÿ°Ù ´Ü¹éÁúÀ» Ĩ »ó¿¡¼­ Á¤Á¦ÇÑ ÈÄ °ËÃâÇÒ º¸À¯ ºÐÀÚ¸¦ ÀÌ¿ÂÈ­ÇÏ´Â »õ·Î¿î ±â¼úÀ̸ç, LFD ±â¼ú Çõ½ÅÀÇ ¿¹ÀÔ´Ï´Ù. 2021³â Spectris(¿µ±¹)°¡ ±ÔÁ¦ ȯ°æÀ» À§ÇØ Æ¯º°È÷ °³¹ßµÇ¾úÀ¸¸ç ¹ÙÀÌ¿À ÀǾàǰ °³¹ßÀ» ÇâÇÏ´Â Áß¿ä Á¤º¸¸¦ Á¦°øÇÏ´Â ½ÃÂ÷ ÁÖ»ç ¿­·®°è(DSC) ÃֽŠÁøº¸¸¦ ¹ßÇ¥ÇÒ ¿¹Á¤ÀÔ´Ï´Ù. °Ô´Ù°¡ ¹Ì±¹ ±¹¸³À§»ý¿¬±¸¼Ò(NIH)´Â 2020³â°ú 2021³â NIH°¡ Á¦°øÇÏ´Â Àӻ󿬱¸ºñ ÃѾ×ÀÌ °¢°¢ 320¾ï°ú 450¾ï ´Þ·¯°¡ µÉ °ÍÀ¸·Î ÃßÁ¤Çϰí ÀÖ½À´Ï´Ù. ÀÓ»ó ¿¬±¸ ÅõÀÚ´Â Áõ°¡Çϰí ÀÖÀ¸¸ç, Á¶¸¸°£ ½ÃÀåÀ» È®´ë½Ãų Àü¸ÁÀÔ´Ï´Ù. ¶ÇÇÑ °£¼·°è¿¡´Â ½Ã·á ±¼Àý·ü º¯µ¿À» ÁÙÀÌ°í ¶óº§ÀÌ ¾ø´Â ¹Ì¼¼À¯Ã¼°¡ ¾ø´Â »ýüÃþ °£¼·°è °¨Áö ÀåÄ¡ µî ÇýÅÃÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ý¸í°úÇÐ ¿¬±¸È°µ¿ÀÌ È°¹ßÇØÁö°í ±â¼úÀûÀ¸·Î Áøº¸µÈ ÷´Ü ÇÁ·ÎÁ§Æ®°¡ µµÀÔµÊÀ¸·Î½á ¿¹Ãø ±â°£ Áß ½ÃÀå ±âȸ°¡ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª Àåºñ ºñ¿ëÀÌ ³ô±â ¶§¹®¿¡ 2023³âºÎÅÍ 2030³â±îÁö ½ÃÀå ¼ºÀåÀÌ ÀúÇØµË´Ï´Ù.

¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ÀÌ Áö¿ªÀÇ ÇöÀúÇÑ Á¤ºÎ ÁöÃâ°ú ±â¼ú °³¹ßÀ» ÅëÇØ ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå Àüü ¼ºÀåÀ» Áö¹èÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ Áö¿ª ½ÃÀå È®´ë´Â Áúº´ ¹ß»ý·ü »ó½Â°ú ÀÇ¾à ¿¬±¸ ÇÁ·Î±×·¥ È®´ë¿¡µµ ÃßÁøµË´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ªÀº ¹ÙÀÌ¿À ÀǾàǰ »ê¾÷ ¼ºÀå°ú R&D ÅõÀÚ Áõ°¡·Î ÀÎÇØ °¡Àå ºü¸¥ Áö¿ªÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®¿Í ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ¹àÈ÷°í ¾ÕÀ¸·Î ¼ö³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. Á¶»ç ´ë»ó ±¹°¡ »ê¾÷ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» Æ÷ÂøÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø ¿äÀΰú °úÁ¦ µî Áß¿ä Ãø¸é ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ °æÀï »óȲ°ú Á¦Ç° Á¦°ø »ó¼¼ÇÑ ºÐ¼®°ú ´õºÒ¾î ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î ½ÃÀå ÀáÀç ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ¸¶ÄÏ ½º³À¼¦
  • ½ÃÀå, ºÎ¹®º° ½ÃÀå Ãß°è, ¿¹Ãø(2020-2030³â)
    • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : Áö¿ªº°(2020-2030³â)
    • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : Á¦Ç°º°(2020-2030³â)
    • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : ±â¼úº°(2020-2030³â)
    • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : ¿ëµµº°(2020-2030³â)
    • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2030³â)
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ÀüÁ¦ Á¶°Ç

Á¦2Àå ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ ÁøÈ­
    • Á¶»ç ´ë»ó ¹üÀ§
  • Á¶»ç ´ë»ó ¿¬µµ
  • ȯÀ² º¯È¯À²

Á¦3Àå ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå ¿ªÇÐ

  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ÃËÁø ¿äÀÎ
      • ¶óº§ ÇÁ¸® ±â¼ú °í°¨µµÈ­
      • â¾à ÇÁ·Î±×·¥ Áõ°¡
    • ½ÃÀå °úÁ¦
      • ±â±â °íºñ¿ë
    • ½ÃÀå ±âȸ
      • »ý¸í°úÇÐ ¿¬±¸ Ȱ¹ßÈ­
      • ±â¼úÀûÀ¸·Î °í±Þ ÇÁ·ÎÁ§Æ® ¼Ò°³

Á¦4Àå ¼¼°èÀÇ ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå »ê¾÷ ºÐ¼®

  • Æ÷ÅÍÀÇ 5¼¼·Â ¸ðÇü
    • °ø±Þ±â¾÷ Çù»ó·Â
    • ±¸¸ÅÀÚ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷ü À§Çù
    • ´ëüǰ À§Çù
    • °æÀï ±â¾÷ °£ Àû´ë °ü°è
  • Æ÷ÅÍÀÇ 5¼¼·Â ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ȯ°æ
    • ¹ý·ü
  • Åé ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇâµµ ºÐ¼®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ® Á¦¾ð, °á·Ð

Á¦5Àå ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ½º³À¼¦
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : Á¦Ç°º°, ½ÇÀû-ÀáÀç ºÐ¼®
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå, Á¦Ç°º° ÃßÁ¤, ¿¹Ãø(2020-2030³â)
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå, ¼­ºê ºÎ¹®º° ºÐ¼®
    • ¼Ò¸ðǰ
    • ±â±â

Á¦6Àå ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : ±â¼úº°

  • ½ÃÀå ½º³À¼¦
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : ±â¼úº°, ½ÇÀû-ÀáÀç ºÐ¼®
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå ÃßÁ¤, ¿¹Ãø : ±â¼úº°(2020-2030³â)
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå, ¼­ºê ºÎ¹®º° ºÐ¼®
    • ´ë·® ºÐ±¤°è
    • Ç¥¸é ÇöóÁî¸ó °ø¸í(SPR)
    • »ýüÃþ °£¼·¹ý
    • µî¿Â ÀûÁ¤ Ä®·Î¸® ÃøÁ¤
    • ½ÃÂ÷ ÁÖ»ç ¿­·® ÃøÁ¤
    • ±âŸ LFD ±â¼ú

Á¦7Àå ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : ¾ÖÇø®ÄÉÀ̼Ǻ°

  • ½ÃÀå ½º³À¼¦
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : ¿ëµµº°, ½ÇÀû, ÀáÀç ºÐ¼®
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå, ¿ëµµº° ÃßÁ¤, ¿¹Ãø(2020-2030³â)
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå, ¼­ºê ºÎ¹®º° ºÐ¼®
    • °áÇÕ µ¿¿ªÇÐ
    • ¹ÙÀεù ¼­¸ð ´ÙÀ̳ª¹Í½º
    • ³»Àμº ¼ö¿ëü °ËÃâ
    • È÷Æ® È®ÀÎ
    • ¸®µå Á¦³Ê·¹À̼Ç
    • ±âŸ ¾ÖÇø®ÄÉÀ̼Ç

Á¦8Àå ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¸¶ÄÏ ½º³À¼¦
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°, ½ÇÀû-ÀáÀç ºÐ¼®
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå, ÃÖÁ¾ »ç¿ëÀÚº° ÃßÁ¤, ¿¹Ãø(2020-2030³â)
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå, ¼­ºê ºÎ¹® ºÐ¼®
    • Á¦¾àȸ»ç, ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö ±â¾÷
    • Çмú, ¿¬±¸±â°ü
    • ¼öŹ¿¬±¸±â°ü

Á¦9Àå ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå : Áö¿ªº° ºÐ¼®

  • »óÀ§ ÁÖ¿ä±¹
  • »óÀ§ ½ÅÈï±¹
  • ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå, Áö¿ªº° ½ÃÀå ½º³À¼¦
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç°º° ÃßÁ¤, ¿¹Ãø(2020-2030³â)
      • ±â¼úº° ÃßÁ¤, ¿¹Ãø(2020-2030³â)
      • ¾ÖÇø®ÄÉÀÌ¼Ç ³»¿ª ÃßÁ¤°ú ¿¹Ãø(2020-2030³â)
      • ÃÖÁ¾ »ç¿ëÀÚ ³»¿ª ÃßÁ¤°ú ¿¹Ãø(2020-2030³â)
    • ij³ª´Ù
  • À¯·´ ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå ½º³À¼¦
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´ Áö¿ª
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¹«Ç¥Áö °ËÃâ(LFD) ½ÃÀå ½º³À¼¦
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç Áö¿ª
  • ¶óƾ¾Æ¸Þ¸®Ä« ¹«Ç¥Áö °ËÃâ±â(LFD) ½ÃÀå ½º³À¼¦
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿, ¾ÆÇÁ¸®Ä« Áö¿ª
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä« °øÈ­±¹
    • ±âŸ Áßµ¿°ú ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
    • ±â¾÷ 1
    • ȸ»ç2
    • 3»ç
  • Å鸶ÄÏ Àü·«
  • ±â¾÷ ÇÁ·ÎÇÊ
    • Cytiva(Danaher Corporation)
      • ÁÖ¿ä Á¤º¸
      • ÁÖ¿ä ¿ä¾à
      • À繫 Á¤º¸(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° ÁÖ¿ä ¿ä¾à
      • ÃÖ±Ù °³¹ß »óȲ
    • Ametek Inc.
    • Corning Incorporated
    • Horiba Ltd.
    • Malvern Panalytical
    • PerkinElmer Inc.
    • Shimadzu Corporation
    • Thermo Fisher Scientific
    • Fluidic Analytics
    • Waters Corporation

Á¦11Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • ºñÁØ
    • ÃâÆÇ
  • Á¶»ç Ư¡
  • Á¶»ç ÀüÁ¦ Á¶°Ç
NJH 23.06.08

Global Label-Free Detection (LED) Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than 9.1% over the forecast period 2023-2030. The label-free detection market refers to the market for technologies and tools that enable the detection and quantification of biological molecules without the use of labels or markers. This includes technologies such as surface plasmon resonance (SPR), bio-layer interferometry (BLI), isothermal titration calorimetry (ITC), and calorimetry-based assays. The market growth is driven by key factors such as the high sensitivity of label-free technologies and the growing number of drug discovery programs.

Since only native proteins and ligands are used, the fundamental benefit of LFD approaches is that more precise information may be obtained. The development of surface-enhanced laser desorption/ionization (SELDI) time of flight (TOF)-mass spectrometry (MS), a novel technique that offers on-chip purification of the target proteins and subsequent ionisation of the retained molecules to be detected, is one example of an innovation in LFD techniques. In 2021, Spectris (UK) will release the most recent advancement in differential scanning calorimetry (DSC), which was developed especially for regulated settings and provides vital information to direct the development of biopharmaceuticals. Furthermore, the National Institutes for Health (NIH) estimates that the overall amount of clinical research funding provided by the NIH in 2020 and 2021 will be 32 billion and 45 billion USD, respectively. Clinical research investment is rising, which will soon increase the market. In addition, interferometry offers benefits such as reduced variation in the samples' refractive index and label-free, microfluidic-free bio-layer interferometry detection devices. Moreover, growing life science research activity and introduction of technologically advance advanced project enhance the market opportunities in the projected period. However, the high Cost of Instruments stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Label-Free Detection (LED) Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is dominating the overall market growth of the Label Free Detection Market owing to Government spending and technology development which are both significant in the region. The market expansion of the area is also being aided by the rising incidence of disease and the expansion of drug research programs. However, Asia Pacific is expected to be the fastest region owing to the Growing biopharmaceutical industry and Increasing investment in R&D.

Major market players included in this report are:

  • Cytiva (Danaher Corporation)
  • Ametek Inc.
  • Corning Incorporated
  • Horiba Ltd.
  • Malvern Panalytical
  • PerkinElmer Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific
  • Fluidic Analytics
  • Waters Corporation

Recent Developments in the Market:

  • In October 2021, Gator Bio, Inc. introduced its Gator SMAP probe and Gator mFC probe for its GatorPrime and GatorPlus biolayer interferometry (BLI) systems.. The systems are used to study the interactions between tiny molecules and proteins as well as to screen for hybridomas and small peptides.
  • in March 2021, The latest advancement in the range of label-free analytical tools from The Life Science Group Sartorius was the debut of the new, high-performance Octet R series of equipment.

Global Label-Free Detection (LED) Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Product, Technology, Application, End User Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Consumables
  • Instruments

By Technology:

  • Mass Spectrometry
  • Surface Plasmon Resonance (SPR)
  • Bio-Layer Interferometry
  • Isothermal Titration Calorimetry
  • Differential Scanning Calorimetry
  • Other LFD Technologies

By Application:

  • Binding Kinetics
  • Binding Thermodynamics
  • Endogenous Receptor Detection
  • Hit Confirmation
  • Lead Generation
  • Other Applications

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Label-Free Detection (LFD) Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Label-Free Detection (LFD) Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Label-Free Detection (LFD) Market, by Technology, 2020-2030 (USD Billion)
    • 1.2.4. Label-Free Detection (LFD) Market, by Application, 2020-2030 (USD Billion)
    • 1.2.5. Label-Free Detection (LFD) Market, by End User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Label-Free Detection (LFD) Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Label-Free Detection (LFD) Market Dynamics

  • 3.1. Label-Free Detection (LFD) Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. High sensitivity of label free technologies
      • 3.1.1.2. Growing number of drug discovery programs
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Instruments
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing life science research activity
      • 3.1.3.2. Introduction of technologically advanced project

Chapter 4. Global Label-Free Detection (LFD) Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Label-Free Detection (LFD) Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Label-Free Detection (LFD) Market by Product, Performance - Potential Analysis
  • 5.3. Global Label-Free Detection (LFD) Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Label-Free Detection (LFD) Market, Sub Segment Analysis
    • 5.4.1. Consumable
    • 5.4.2. Instruments

Chapter 6. Global Label-Free Detection (LFD) Market, by Technology

  • 6.1. Market Snapshot
  • 6.2. Global Label-Free Detection (LFD) Market by Technology, Performance - Potential Analysis
  • 6.3. Global Label-Free Detection (LFD) Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
  • 6.4. Label-Free Detection (LFD) Market, Sub Segment Analysis
    • 6.4.1. Mass Spectrometry
    • 6.4.2. Surface Plasmon Resonance (SPR)
    • 6.4.3. Bio-Layer Interferometry
    • 6.4.4. Isothermal Titration Calorimetry
    • 6.4.5. Differential Scanning Calorimetry
    • 6.4.6. Other LFD Technologies

Chapter 7. Global Label-Free Detection (LFD) Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Label-Free Detection (LFD) Market by Application, Performance - Potential Analysis
  • 7.3. Global Label-Free Detection (LFD) Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 7.4. Label-Free Detection (LFD) Market, Sub Segment Analysis
    • 7.4.1. Binding Kinetics
    • 7.4.2. Binding Thermodynamics
    • 7.4.3. Endogenous Receptor Detection
    • 7.4.4. Hit Confirmation
    • 7.4.5. Lead Generation
    • 7.4.6. Other Applications

Chapter 8. Global Label-Free Detection (LFD) Market, by End User

  • 8.1. Market Snapshot
  • 8.2. Global Label-Free Detection (LFD) Market by End User, Performance - Potential Analysis
  • 8.3. Global Label-Free Detection (LFD) Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
  • 8.4. Label-Free Detection (LFD) Market, Sub Segment Analysis
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. Academic & Research Institutes
    • 8.4.3. Contract Research Organization

Chapter 9. Global Label-Free Detection (LFD) Market, Regional Analysis

  • 9.1. Top Leading Countries
  • 9.2. Top Emerging Countries
  • 9.3. Label-Free Detection (LFD) Market, Regional Market Snapshot
  • 9.4. North America Label-Free Detection (LFD) Market
    • 9.4.1. U.S. Label-Free Detection (LFD) Market
      • 9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 9.4.1.2. Technology breakdown estimates & forecasts, 2020-2030
      • 9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
      • 9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
    • 9.4.2. Canada Label-Free Detection (LFD) Market
  • 9.5. Europe Label-Free Detection (LFD) Market Snapshot
    • 9.5.1. U.K. Label-Free Detection (LFD) Market
    • 9.5.2. Germany Label-Free Detection (LFD) Market
    • 9.5.3. France Label-Free Detection (LFD) Market
    • 9.5.4. Spain Label-Free Detection (LFD) Market
    • 9.5.5. Italy Label-Free Detection (LFD) Market
    • 9.5.6. Rest of Europe Label-Free Detection (LFD) Market
  • 9.6. Asia-Pacific Label-Free Detection (LFD) Market Snapshot
    • 9.6.1. China Label-Free Detection (LFD) Market
    • 9.6.2. India Label-Free Detection (LFD) Market
    • 9.6.3. Japan Label-Free Detection (LFD) Market
    • 9.6.4. Australia Label-Free Detection (LFD) Market
    • 9.6.5. South Korea Label-Free Detection (LFD) Market
    • 9.6.6. Rest of Asia Pacific Label-Free Detection (LFD) Market
  • 9.7. Latin America Label-Free Detection (LFD) Market Snapshot
    • 9.7.1. Brazil Label-Free Detection (LFD) Market
    • 9.7.2. Mexico Label-Free Detection (LFD) Market
  • 9.8. Middle East & Africa Label-Free Detection (LFD) Market
    • 9.8.1. Saudi Arabia Label-Free Detection (LFD) Market
    • 9.8.2. South Africa Label-Free Detection (LFD) Market
    • 9.8.3. Rest of Middle East & Africa Label-Free Detection (LFD) Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Company 1
    • 10.1.2. Company 2
    • 10.1.3. Company 3
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Cytiva (Danaher Corporation)
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Recent Developments
    • 10.3.2. Ametek Inc.
    • 10.3.3. Corning Incorporated
    • 10.3.4. Horiba Ltd.
    • 10.3.5. Malvern Panalytical
    • 10.3.6. PerkinElmer Inc.
    • 10.3.7. Shimadzu Corporation
    • 10.3.8. Thermo Fisher Scientific
    • 10.3.9. Fluidic Analytics
    • 10.3.10. Waters Corporation

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦